COVID-19

Views & Analysis

Vertex Pharma’s vision for reimbursement innovation

As regional vice president for Northern Europe & Australia, Simon Lem led the digital launch of Vertex Pharma’s novel cystic fibrosis drug Kaftrio.

News

Could an antidepressant be used to treat COVID-19?

The antidepressant fluvoxamine merits further investigation as a potential treatment for COVID-19 according to findings of a preliminary trial.

News

UK eyes access deal as Moderna’s COVID-19 shot hits the mark

Moderna is the third group in a week to report encouraging phase 3 data with a coronavirus vaccine, saying today that its mRNA-1273 shot had an efficacy of 94.5% in the 30,000-patient COVE

News

Guido Rasi steps down, handing the running of EMA to Emer Co...

EMA executive director Guido Rasi has ended his second term at the helm of the EU medicines regulator, with Emer Cooke taking the wheel and becoming the first women in the role.

News

Janssen J&J Johnson and Johnson pharmaceutical companies

J&J begins trial of two-dose COVID-19 vaccine regimen

Johnson & Johnson has begun a second phase 3 trial of its potential COVID-19 vaccine, including sites in the UK, testing whether it works as a two-dose regimen.

Views & Analysis

Pharma brands must 'up the ante' in their digital presence

Since COVID-19 hit, many industries have shifted a heavier weighting of their business into the online world, relying on e-commerce and digital engagement to counterbalance the reduced abil

Vertex Pharma’s vision for reimbursement innovation

Could an antidepressant be used to treat COVID-19?

UK eyes access deal as Moderna’s COVID-19 shot hits the mark

Guido Rasi steps down, handing the running of EMA to Emer Co...

J&J begins trial of two-dose COVID-19 vaccine regimen

Pharma brands must 'up the ante' in their digital presence

Scribe Therapeutics joins the IPO queue

Discover a new era of healthcare panel engagement: Grounded ...

COVID-19

Editor's Picks